Provided by Tiger Trade Technology Pte. Ltd.

Clearmind Medicine, Inc.

5.84
-0.1600-2.67%
Post-market: 5.840.00000.00%16:10 EDT
Volume:35.34K
Turnover:208.58K
Market Cap:2.46M
PE:-0.05
High:6.17
Open:5.89
Low:5.70
Close:6.00
52wk High:3,840.00
52wk Low:5.25
Shares:420.89K
Float Shares:420.71K
Volume Ratio:1.18
T/O Rate:8.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-118.4105
EPS(LYR):-2,427.8177
ROE:-106.98%
ROA:-53.08%
PB:0.19
PE(LYR):0.00

Loading ...

SciSparc, Clearmind publish U.S. patent application for MDMA-PEA combination

TIPRANKS
·
Aug 24

Clearmind Medicine Says US Publishes MDMA-PEA Patent Application for PTSD Treatment

Reuters
·
Aug 24

Clearmind Advances Mdma-N-Acylethanolamines Ip for the Treatment of Ptsd Amid Rising U.S. Federal Support for Psychedelic Innovation

THOMSON REUTERS
·
Aug 24

Clearmind Advances CMND-100 into Alcohol Use Disorder Patients After Phase I/II Safety Milestone

Reuters
·
Aug 13

Clearmind Advances Cmnd-100 to Alcohol Use Disorder Patients After Achieving Primary Safety Endpoint

THOMSON REUTERS
·
Aug 13

Clearmind Medicine Announces Positive Permeation Results for Intranasal Meai Formulation

Reuters
·
Aug 11

Clearmind Medicine reports MEAI development program permeation study results

TIPRANKS
·
Aug 11

Clearmind Medicine Reports Positive Permeation Results for Intranasal MEAI Formulation Study

Reuters
·
Aug 11

Clearmind Medicine - Intranasal Meai Shows Enhanced Nasal Retention Without Compromising Permeation

THOMSON REUTERS
·
Aug 11

Clearmind Medicine reports DSMB approves advancing Phase I/II AUD study

TIPRANKS
·
Aug 06

Clearmind Advances CMND-100 Alcohol Use Disorder Trial into Patient Testing After Phase I Safety Readout

Reuters
·
Aug 06

Clearmind Reaches Key Clinical Trial Milestone as Dsmb Unanimously Clears Progression in AUD Study

THOMSON REUTERS
·
Aug 06

Clearmind Signs LOI to Buy 51% Stake in EV Wireless Charging Firm for $2.5 Million

Reuters
·
Aug 03

Clearmind Medicine Signs Letter of Intent to Acquire 51% Majority Stake in EV Wireless Charging Solutions for Automated Parking Systems Company

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - to Extend $1.50 Mln Loan at 4% Interest, Repayable in Two Years

THOMSON REUTERS
·
Aug 03

Clearmind Medicine - Deal Valued at $2.50 Mln for 51% Majority Stake

THOMSON REUTERS
·
Aug 03

Psychedelic: Clearmind reports safety findings for CMND-100

TIPRANKS
·
Jul 30

Clearmind Medicine announces safety results from Part A of CMND-100 tral

TIPRANKS
·
Jul 30

Clearmind Reports Positive Safety, Tolerability in Cmnd-100 Phase I/II Trial Part a Dose Escalation

Reuters
·
Jul 30

Clearmind Medicine - Study Achieves Primary Endpoint of Safety and Tolerability for Cmnd-100

THOMSON REUTERS
·
Jul 30